Oakland, California, June 24, 2022 (GLOBE NEWSWIRE) — The California State Court Judge overseeing the Ranitidine Products Cases JCCP NO. 5150 issued a pretrial order this week establishing a trial schedule for the Zantac litigation in California. In his order, the Honorable Judge Evelio M. Grillo for the California Superior Court of Alameda County confirmed the first four Zantac (ranitidine) bellwether trials in the California Zantac JCCP (Judicial Council Coordination Proceedings), with the first taking place on February 13, 2023 in Oakland.
This is welcome news for the thousands of claimants throughout California alleging that drug makers Boehringer Ingelheim, Sanofi, Pfizer, and GlaxoSmithKline (GSK) failed to warn about the link between Zantac (generic: ranitidine) and cancer.
Pretrial Order No. 4 laid out some important dates in the California Zantac litigation:
January 25, 2023 – Court hearing on Sargon. A Sargon hearing allows the legal teams for both sides of a legal dispute to present their expert witnesses and educate the court on the science that underpins their arguments. After carefully considering the expert opinions, Judge Grillo will decide whether the experts on both sides used sound logic and valid methodologies to arrive at their scientific opinions. If Judge Grillo determines that the experts used valid methodologies, then Zantac cases in the JCCP can proceed to trial and the experts will be allowed to provide evidence and testimony on…
